RNA-Bio

RNA Bio is a Silicon Valley-based biotechnology startup specializing in the development of personalized mRNA-based therapeutics and vaccines. The company leverages a sophisticated multi-omics platform—integrating DNA, RNA, and protein sequencing with mass spectrometry—to identify tumor-specific neoantigens and design highly targeted cancer vaccines. Beyond oncology, RNA Bio is advancing a diverse pipeline that includes mRNA therapies for metabolic disorders (notably a GLP-1 mRNA for obesity), reproductive health, and veterinary applications. By utilizing AI-driven design and modular mRNA technology, the company aims to provide precise, adaptable, and effective treatments that minimize off-target effects and address unmet medical needs across human and animal health.